Proteomic Analysis of Hepatic Fibrosis in Human Immunodeficiency Virus–Associated Nonalcoholic Fatty Liver Disease Demonstrates Up-regulation of Immune Response and Tissue Repair Pathways

Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK/TGF-β1 signaling pathway

(2021) Qing-shan Liang et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-Infection and Nonalcoholic Fatty Liver Disease

(2021) Takara L Stanley et al.   CLINICAL INFECTIOUS DISEASES

Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach

(2021) Lindsay T. Fourman et al.   Scientific Reports

Clinical Predictors of Liver Fibrosis Presence and Progression in HIV-Associated NAFLD

(2020) Lindsay T Fourman et al.   CLINICAL INFECTIOUS DISEASES

Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression

(2020) Moisés Martínez-Castillo et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Hepatic Stellate Cell–Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis

(2020) Michitaka Matsuda et al.   SEMINARS IN LIVER DISEASE

Osteopontin takes center stage in chronic liver disease

(2020) Zhuolun Song et al.   HEPATOLOGY

Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease

(2020) Reem Al-Qarni et al.   MEDICINE

Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV–HCV-Coinfected Individuals

(2020) Xiaochen Chen et al.   International Journal of Environmental Research and Public Health

Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease

(2019) Lili Niu et al.   Molecular Systems Biology

Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial

(2019) Takara L Stanley et al.   Lancet HIV

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Novel insights into the function and dynamics of extracellular matrix in liver fibrosis

(2015) Morten A. Karsdal et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm3Is More Pronounced Among Women Than Men

(2015) Amy S. Baranoski et al.   Open Forum Infectious Diseases

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma

(2014) Zhixiong Cai et al.   CANCER SCIENCE

IGFBPrP1 induces liver fibrosis by inducing hepatic stellate cell activation and hepatocyte apoptosisviaSmad2/3 signaling

(2014) Yun Zhang   WORLD JOURNAL OF GASTROENTEROLOGY

Decorin interferes with platelet-derived growth factor receptor signaling in experimental hepatocarcinogenesis

(2013) Kornélia Baghy et al.   FEBS Journal

Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCV

(2012) Berkeley N. Limketkai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Notch3 regulates the activation of hepatic stellate cells

(2012) Yi-Xiong Chen   WORLD JOURNAL OF GASTROENTEROLOGY

Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

(2011) Christer Baeck et al.   GUT

Overexpression of Cathepsin Z Contributes to Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

(2011) Jian Wang et al.   PLoS One

Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients

(2010) J Macías et al.   HIV MEDICINE

CD137-Mediated Pathogenesis from Chronic Hepatitis to Hepatocellular Carcinoma in Hepatitis B Virus-Transgenic Mice

(2010) J. Wang et al.   JOURNAL OF IMMUNOLOGY

Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice

(2010) Kornélia Baghy et al.   LABORATORY INVESTIGATION

Identification of novel markers for liver fibrosis in HIV/hepatitis C virus coinfected individuals using genomics-based approach

(2009) Daniel L Suzman et al.   AIDS

Insulin-like growth factor binding protein-7 induces activation and transdifferentiation of hepatic stellate cells in vitro

(2009) Li-Xin Liu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Lymphotoxin-β receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury

(2008) Richard G. Ruddell et al.   HEPATOLOGY

Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients

(2008) Yoshiyuki Takahara et al.   WORLD JOURNAL OF GASTROENTEROLOGY